The effectiveness of annual versus biennial mass chemotherapy in reducing morbidity due to schistosomiasis: A prospective study in Gezira-Managil, Sudan

American Journal of Tropical Medicine and Hygiene

Volumn 54, Issue 2, 1996, Pages 140-145

  Homeida, Mamoun M A ^a   Eltoum, Isam A ^b   Ali, Magdi M ^c   Suliaman, Suad M ^c   Elobied, Elshiekh A ^d   Mansour, Mahmoud ^c   Saad, Ahmed M ^a   Bennett, James L ^e  

^a UNIVERSITY OF KHARTOUM   (Sudan)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^c National Health Laboratory Sudan   (Sudan)

^d BRIGHAM YOUNG UNIVERSITY   (United States)

^e MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRAZIQUANTEL;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; CHILD; DIARRHEA; ENDEMIC DISEASE; FEMALE; FEVER; HEADACHE; HEALTH PROMOTION; HEPATOSPLENOMEGALY; HUMAN; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MELENA; ORAL DRUG ADMINISTRATION; PREVALENCE; REINFECTION; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SUDAN;

SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMA MANSONI;

EID: 0030006165     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1996.54.140     Document Type: Article

References (20)

1. World Health Organization, 1993. The control of schistosomiasis: second report of the WHO expert committee. World Health Organ Tech Rep Ser 830.
2. El Gaddal AA, 1985. The Blue Nile Health Project: a comprehensive approach to the prevention and control of water associated diseases in the Sudan. J Trop Med Hyg 88: 47-56.
3. Eltoumn IA, Sulaiman SM, Elturabi H, Mahgoub E, Homeida MMA, 1993. Infection with Schistosoma mansoni in two different endemic areas: a comparative population-based study in Elzidab and Gezira-Managil irrigation schemes, Sudan. J. Trop Med Hyg 96: 100-106.
4. Homeida M, Saad A, Dafalla A, Suliaman S, Eltom I, Nash T, Bennett JL, 1988. Morbidity associated with Schistosoma mansoni infection as determined by ultrasound: a study in Gezira, Sudan. Am J Trop Med Hyg 39: 196-201.
5. Saad AMA, Homeida M, Eltom I, Nash T, Bennett JL, Hassan MA, 1991, Oesophageal varices in the region of Sudan endemic for S. mansoni. Br J Surg 78: 1252-1253.
6. Warren KS, Bundy DAP, Anderson RM, Davis AR, Henderson DA, Jamison DT, Prescott N, Senft A, 1993. Helminth infections. Jamison DT, Mosely WH, Measham AR, Babadilla JL, eds. Disease Control Priorities in Developing Countries. New York: Oxford University Press, 131-160.
7. Homeida MA, El Tom I, Nash T, Bennett JL, 1991. Association of therapeutic activity of praziquantel with the reversal of Symmers' fibrosis induced by Schistosoma mansoni. Am J Trop Med Hyg 45: 360-365.
8. Doehring-Schwerdtfeger E, Abdel-Rahim IM, Kaiser C, Kardoff R, Franke D, Schlake J, El-Seikh M, Mohamed-Ali Q, Ehrich JHH, 1992. Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity 23 months after treatment with praziquantel. Am J Trop Med Hyg 46: 409-415.
9. Ali QM, Doehring-Schwerdtfeger E, Abdel-Rahim IM, Schlake J, Kardoff R, Franke D, Kaiser C, Elsheikh M, Abdalla M, Schafer P, Ehrich JHH, 1991. Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity seven months after treatment with praziquantel. Am J Trop Med Hyg 44: 444-451.
10. Homeida MA, Fenwick A, Defalla AA, Suliaman S, Kardaman MW, Eltom I, Nash T. Bennett JL, 1988. Effect of antischistosomal chemotherapy on prevalence of Symmers' periportal fibrosis in Sudanese villages. Lancet ii: 437-440.
11. Teesdale CH, Amin MA, 1976. A simple thick smear technique for the diagnosis of Schistosoma mansoni. Bull World Health Organ 54: 703-705.
12. Andrade ZA, Peixoto E, Guerret S, Grimaund JA, 1992. Hepatic connective tissue changes in hepatosplenic schistosomiasis. Hum Pathol 23: 566-573.
13. Zwingerberger K, Richeter J. Vergetti JGS, Feldmeier H, 1990. Praziquantel in the treatment of hepatosplenic schistosomiasis: biochemical disease markers indicate deceleration of fibrogenesis and diminution of portal flow. Trans R Soc Trop Med Hyg 84: 252-256.
14. Gryseels B, 1989. The relevance of schistosomiasis for public health. Trop Med Parasitol 40: 134-142.
15. Gryseels B, Polderman AM, 1991. Morbidity due to schistosomiasis mansoni and its control in sub-Saharan Africa. Parasitol Today 15: 244-245.
16. Eltoum IA, Taha, T Saad, AM Suliaman S, Nash T, Bennett JL, Homeida MMA, 1994. Predictors of upper gastrointestinal bleeding in patients with bilharzial periportal fibrosis. Br J Surg 81: 996-999.
17. Cheever AW, Andrade ZA, 1967. Pathological lesions associated with Schistosoma mansoni infection in man. Trans R Soc Trop Med Hyg. 61: 626-639.
18. Sleigh AC, Hoff R, Mott KE, Maguire JH, Silva, JT, 1983. Manson's schistosomiasis in Brazil: 11-year evaluation of successful disease control with oxamniquine. Lancet i: 635-637.
19. Webbe G, Jordan A, 1993. Control. Jordan P, Webbe G, Sturrock RF, eds. Human Schistosomiasis. Wilingford, United Kingdom: CAB International, 405-451.
20. Gryseels B, Nkulikyinka L, Engels D, 1991. Repeated community-based chemotherapy for control of Schistosoma mansoni: effect of screening and selective treatment on prevalence and intensities of infection. Am J Trop Med Hyg 45: 509-517.